Search Results

Prime Therapeutics LLC / Magellan Rx Management, LLC continues to publish award-winning and industry-leading research on a range of clinical topics impacting the health care and pharmacy benefit management industry. Thought leaders from Prime/MRx will present eight research studies at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, April 15-18 in New Orleans.

Prime Therapeutics LLC /Magellan Rx is proud to announce that Magellan Rx Pharmacy, LLC, MRx’s specialty pharmacy, has earned URAC reaccreditation for Specialty Pharmacy.

Prime Therapeutics LLC and Magellan Rx Management LLC released the 13th annual Medical Pharmacy Trend Report™, featuring a comprehensive view of provider-administered medical benefit drug trends, the largest driver of specialty drug spend.

Prime Therapeutics LLC/Magellan Rx Management (Prime/MRx) will present three research studies at the 2023 Academy of Managed Care Pharmacy (AMCP) Nexus event, October 16-19 in Orlando, Fla.

Prime Therapeutics LLC announces that Magellan Rx Pharmacy, LLC, Prime’s specialty pharmacy, entered into a multi-year deal with Inovalon, a leading provider of cloud-based software solutions empowering data-driven health care, for its ScriptMed® Cloud platform.

Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.

Centene Corporation announced that it has completed the previously announced divestiture of Magellan Specialty Health to Evolent Health, Inc..

Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Magellan Diagnostics resumed manufacturing and distribution of their LeadCare® II test kits.

Centene Corporation announced that it has successfully completed the previously announced divestiture of Magellan Rx to Prime Therapeutics LLC.

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) and Magellan Rx Management, (Magellan Rx), a Prime Therapeutics company, will present seven research studies at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, March 21-24 in San Antonio, Texas.